The lambda gene immunoglobulin repertoire of human neonatal B cells
详细信息 查看全文
- 作者：P. Richl ; U. Stern ; P.E. Lipsky ; H.J. Girschick
- 关键词：Human neonatal B lymphocytes ; V lambda repertoire ; Terminal desoxynucleotidyl transferase
- 刊名：Molecular Immunology
- 出版年：2008
- 出版时间：January 2008
- 年：2008
- 卷：45
- 期：2
- 页码：320-327
- 全文大小：394 K
文摘
The dynamics of immunoglobulin rearrangements and selection, which depend on age, antigen exposure and tolerance functions, are only partly understood. Thus, we analyzed and compared the lambda chain immunoglobulin repertoire of individual IgD+ human neonatal B cells with the adult peripheral B cell VλJλ repertoire. Some Vλ genes, 4C, 2A2, 2B2, 5A, 1G and 4B, were overexpressed in the non-productive neonatal repertoire, whereas other Vλ genes (2E, 2A2, 3H, 2B2, 1C and 1G) were overexpressed in the productive repertoire. The adult B cell repertoire revealed nearly the same predominance of genes in the non-productive and productive repertoire. A comparison of the non-productive and productive repertoire indicated that the genes 3H and 1C were positively selected, whereas the genes 4C, 2A1, 3I, 5A, 9A, 4A and 4B were negatively selected. All four functional Jλ genes were used in both repertoires. Jλ2/3 was used mainly. Insertions of non-templated nucleotides at the VλJλ-junction by the enzyme TdT were less frequent as compared to the adult, but the CDR3 length was the same. Comparison of CD5+IgD+ and CD5−IgD+ B cells revealed no differences between neonatal productive rearrangements. However, the genes 1C and 1G were used more often in the non-productive repertoire of CD5+ B cells, whereas gene 4B was used significantly more frequent in CD5− B cells. These data provide evidence that the primary usage and subsequent selection of Vλ genes in the neonate are surprisingly comparable with the adult. This suggests that selection into the productive Vλ repertoire in principal might be driven mainly by autoantigens in the newborn, as well as in adulthood, since newborns have not been exposed to exogenous antigens.